WBC
BIO icon

Westpac Banking Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Westpac Banking Corp’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,796
Closed -$1.44M – 519
2023
Q2 		$1.44M Sell
3,796
-4,459
-54% -$1.81M 0.1% 225
2023
Q1 		$3.95M Sell
8,255
-4,300
-34% -$2.01M 0.05% 385
2022
Q4 		$5.28M Buy
12,555
+750
+6% +$303K 0.08% 315
2022
Q3 		$4.92M Hold
11,805
– – 0.08% 336
2022
Q2 		$5.84M Sell
11,805
-278
-2% -$145K 0.08% 332
2022
Q1 		$6.81M Buy
12,083
+682
+6% +$411K 0.08% 324
2021
Q4 		$8.61M Sell
11,401
-829
-7% -$620K 0.09% 286
2021
Q3 		$9.12M Sell
12,230
-1,100
-8% -$824K 0.1% 278
2021
Q2 		$8.59M Buy
13,330
+400
+3% +$243K 0.09% 302
2021
Q1 		$7.39M Sell
12,930
-1,300
-9% -$770K 0.08% 312
2020
Q4 		$8.3M Sell
14,230
-714
-5% -$407K 0.09% 285
2020
Q3 		$7.7M Buy
14,944
+100
+0.7% +$50.6K 0.1% 259
2020
Q2 		$6.7M Buy
14,844
+13,030
+718% +$5.75M 0.1% 269
2020
Q1 		$636K Hold
1,814
– – 0.01% 686
2019
Q4 		$671K Buy
+1,814
New +$640K 0.01% 763
2014
Q3 		– Sell
-2,391
Closed -$286K – 935
2014
Q2 		$286K Buy
2,391
+777
+48% +$94.9K ﹤0.01% 841
2014
Q1 		$207K Buy
+1,614
New +$207K ﹤0.01% 827

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Westpac Banking Corp's BIO Position: Q3 2023 in Review

Westpac Banking Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2023, closing a stake of 3,796 shares — an estimated $1.44M sold.

Westpac Banking Corp first reported a position in BIO in Q1 2014 and held it in 17 quarters. The position peaked at $9.12M in Q3 2021. 468 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

  • Westpac Banking Corp reported no remaining Bio-Rad Laboratories Class A position as of Q3 2023 after selling out during the quarter.
  • Westpac Banking Corp sold 3,796 Bio-Rad Laboratories Class A shares in Q3 2023, an estimated $1.44M.
  • Westpac Banking Corp first reported a position in Bio-Rad Laboratories Class A in Q1 2014 and held it in 17 quarters.
  • Westpac Banking Corp's Bio-Rad Laboratories Class A position peaked at $9.12M in Q3 2021.
  • 468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on Westpac Banking Corp's 13F filing for Q3 2023, filed 13 Nov 2023.